======= CARNS1 ======= == Gene Information == * **Official Symbol**: CARNS1 * **Official Name**: carnosine synthase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57571|57571]] * **UniProt**: [[https://www.uniprot.org/uniprot/A5YM72|A5YM72]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CARNS1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CARNS1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/613368|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Catalyzes the synthesis of carnosine and homocarnosine. Carnosine is synthesized more efficiently than homocarnosine. {ECO:0000269|PubMed:20097752}. No Pfam Domain information is available for this gene. |carnosine biosynthetic process| |homocarnosine synthase activity| |carnosine synthase activity| |carnosine metabolic process| |histidine catabolic process| |imidazole-containing compound catabolic process| |histidine metabolic process| |imidazole-containing compound metabolic process| |FMN binding| |aromatic amino acid family catabolic process| |aromatic amino acid family metabolic process| |cellular modified amino acid biosynthetic process| |alpha-amino acid catabolic process| |cellular amino acid catabolic process| |cellular modified amino acid metabolic process| |alpha-amino acid metabolic process| |ATPase activity| |carboxylic acid catabolic process| |organic acid catabolic process| |carboxylic acid biosynthetic process| |organic acid biosynthetic process| |cellular amino acid metabolic process| |peptide biosynthetic process| |heterocycle catabolic process| |cellular nitrogen compound catabolic process| |small molecule catabolic process| |aromatic compound catabolic process| |cellular component| |organic cyclic compound catabolic process| |drug metabolic process| |amide biosynthetic process| |peptide metabolic process| |small molecule biosynthetic process| |cellular amide metabolic process| |carboxylic acid metabolic process| |oxoacid metabolic process| |organic acid metabolic process| |organonitrogen compound catabolic process| |organonitrogen compound biosynthetic process| |ATP binding| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-1.75| |[[:results:exp40|2-Methoxyestradiol 0.2μM R01 exp40]]|-1.73| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|-1.7| |[[:results:exp280|Daidzin 10μM R06 exp280]]|1.71| |[[:results:exp465|Cannabidiol 13μM R08 exp465]]|1.77| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|1.84| |[[:results:exp345|Cidofovir 10μM R07 exp345]]|1.87| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.705| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5427 * **Expression level (log2 read counts)**: 0.61 {{:chemogenomics:nalm6 dist.png?nolink |}}